The FDA has approved a 10mcg formulation of Vagifem (estradiol vaginal tablets, from Novo Nordisk) for the treatment of atrophic vaginitis due to menopause. This approval is based on clinical data ...

ROCHESTER, MINN. -- About 40 percent of women past menopause have atrophic vaginitis, an inflammation of or an irritation of the vaginal tissues and a decrease in lubrication. The often-overlooked ...

PRINCETON, N.J. The Food and Drug Administration has approved a 10-microgram formulation of a suppository for treating atrophic vaginitis. Danish drug maker Novo Nordisk announced Wednesday the ...

If a woman is being treated with topical estrogen for atrophic vaginitis, does she need to use a progestin (synthetic progesterone) to protect the uterus? The best clinical practice at this point in ...

The Food and Drug Administration has approved Aubobindo’s estradiol vaginal inserts, 10 mcg, which is the generic of Novo Nordisk’s Vagifem. The product will be launched in the second quarter of 2025.

Please provide your email address to receive an email when new articles are posted on . At 12 weeks, vaginal hyaluronic acid and vaginal estrogen were associated with genitourinary syndrome of ...